Trademark: 77783471
Word
GLENERIC
Status
Dead
Status Code
606
Status Date
Monday, May 14, 2012
Serial Number
77783471
Mark Type
4000
Filing Date
Friday, July 17, 2009
Published for Opposition
Tuesday, August 17, 2010
Abandoned Date
Monday, May 14, 2012

Trademark Owner History
Glenmark Pharmaceuticals Limited - Owner At Publication

Classifications
5 Pharmaceuticals and Medicinal preparations, namely, opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain

Trademark Events
May 14, 2012
Abandonment Notice Mailed - No Use Statement Filed
May 14, 2012
Abandonment - No Use Statement Filed
Oct 15, 2011
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2011
Extension 2 Granted
Oct 12, 2011
Extension 2 Filed
Oct 13, 2011
Case Assigned To Intent To Use Paralegal
Oct 12, 2011
Teas Extension Received
Mar 9, 2011
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2011
Extension 1 Granted
Mar 7, 2011
Extension 1 Filed
Mar 7, 2011
Teas Extension Received
Oct 12, 2010
Noa E-Mailed - Sou Required From Applicant
Aug 17, 2010
Official Gazette Publication Confirmation E-Mailed
Aug 17, 2010
Published For Opposition
Jul 9, 2010
Law Office Publication Review Completed
Jul 8, 2010
Approved For Pub - Principal Register
Jun 9, 2010
Examiner's Amendment Entered
Jun 9, 2010
Notification Of Examiners Amendment E-Mailed
Jun 9, 2010
Examiners Amendment E-Mailed
Jun 9, 2010
Examiners Amendment -Written
Jun 5, 2010
Data Modification Completed
Jun 3, 2010
Assigned To Lie
May 27, 2010
Teas/Email Correspondence Entered
May 27, 2010
Correspondence Received In Law Office
May 27, 2010
Teas Response To Suspension Inquiry Received
Apr 27, 2010
Notification Of Letter Of Suspension E-Mailed
Apr 27, 2010
Letter Of Suspension E-Mailed
Apr 27, 2010
Suspension Letter Written
Apr 14, 2010
Teas/Email Correspondence Entered
Apr 14, 2010
Correspondence Received In Law Office
Apr 14, 2010
Teas Response To Office Action Received
Oct 20, 2009
Notification Of Non-Final Action E-Mailed
Oct 20, 2009
Non-Final Action E-Mailed
Oct 20, 2009
Non-Final Action Written
Oct 20, 2009
Assigned To Examiner
Jul 22, 2009
Notice Of Pseudo Mark Mailed
Jul 21, 2009
New Application Office Supplied Data Entered In Tram
Jul 21, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24